How should clinicians interpret cardiac troponin values in patients with ESRD?
作者信息
Jain Nishank, Hedayati S Susan
机构信息
Division of Nephrology, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
出版信息
Semin Dial. 2011 Jul-Aug;24(4):398-400. doi: 10.1111/j.1525-139X.2011.00912.x.
Abstract
摘要
相似文献
1
How should clinicians interpret cardiac troponin values in patients with ESRD?临床医生应如何解读终末期肾病患者的心肌肌钙蛋白值？
Semin Dial. 2011 Jul-Aug;24(4):398-400. doi: 10.1111/j.1525-139X.2011.00912.x.
2
The use and interpretation of troponin in ESRD patients.
Semin Dial. 2014 Nov-Dec;27(6):545-7. doi: 10.1111/sdi.12263. Epub 2014 Jul 3.
3
Cardiac biomarkers in the new millennium.
Semin Dial. 2001 Sep-Oct;14(5):322-3. doi: 10.1046/j.1525-139x.2001.00079.x.
4
MicroRNAs in patients on chronic hemodialysis (MINOS study).慢性血液透析患者中的 microRNAs（MINOS 研究）。
Clin J Am Soc Nephrol. 2012 Apr;7(4):619-23. doi: 10.2215/CJN.10471011. Epub 2012 Feb 16.
5
Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death.N末端B型利钠肽原、高敏C反应蛋白以及心肌肌钙蛋白T和I对终末期肾病全因死亡的多生物标志物风险分层
Clin Chem. 2004 Dec;50(12):2279-85. doi: 10.1373/clinchem.2004.035741. Epub 2004 Sep 13.
6
Use of cardiac biomarkers in end-stage renal disease.心脏生物标志物在终末期肾病中的应用。
J Am Soc Nephrol. 2008 Sep;19(9):1643-52. doi: 10.1681/ASN.2008010012. Epub 2008 Mar 5.
7
Cardiac biomarkers in renal disease: the fog is slowly lifting.肾脏疾病中的心脏生物标志物：迷雾正在慢慢消散。
Clin Chem. 2004 Dec;50(12):2233-5. doi: 10.1373/clinchem.2004.041566.
8
A green light for troponin T in the cardiovascular risk stratification of continuous ambulatory peritoneal dialysis patients?肌钙蛋白T在持续非卧床腹膜透析患者心血管风险分层中能否发挥作用？
Kidney Int. 2006 Aug;70(3):408-10. doi: 10.1038/sj.ki.5001558.
9
Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.高敏心肌肌钙蛋白T和利钠肽与终末期肾病发生的关联：社区动脉粥样硬化风险（ARIC）研究
Am J Kidney Dis. 2015 Apr;65(4):550-8. doi: 10.1053/j.ajkd.2014.08.021. Epub 2014 Oct 23.
10
Haemodialysis patients longitudinally assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and cardiac troponin I assays.通过高敏心肌肌钙蛋白T以及商用心肌肌钙蛋白T和心肌肌钙蛋白I检测法对血液透析患者进行纵向评估。
Ann Clin Biochem. 2009 Jul;46(Pt 4):283-90. doi: 10.1258/acb.2009.008197. Epub 2009 May 19.
引用本文的文献
1
Association of cardiac troponin I level with in-hospital and late mortality in dialysis patients.透析患者心肌肌钙蛋白I水平与院内及晚期死亡率的关联
J Res Med Sci. 2025 Jan 30;30:8. doi: 10.4103/jrms.jrms_658_23. eCollection 2025.
2
Clinical Interpretation of Serum Troponin in the Era of High-Sensitivity Testing.高灵敏度检测时代血清肌钙蛋白的临床解读
Diagnostics (Basel). 2024 Feb 26;14(5):503. doi: 10.3390/diagnostics14050503.
3
Comparative Effectiveness and Safety of Oral P2Y12 Inhibitors in Patients on Chronic Dialysis.口服P2Y12抑制剂在慢性透析患者中的疗效与安全性比较
Kidney Int Rep. 2021 Jul 3;6(9):2381-2391. doi: 10.1016/j.ekir.2021.06.031. eCollection 2021 Sep.
4
Response to Zhou et al. regarding Cardiac injury prediction and lymphocyte immunity and inflammation analysis in hospitalized patients with coronavirus disease 2019 (COVID-19).关于周等人对2019冠状病毒病（COVID-19）住院患者心脏损伤预测及淋巴细胞免疫与炎症分析的回应。
Int J Cardiol. 2021 Jun 15;333:249. doi: 10.1016/j.ijcard.2021.02.052. Epub 2021 Feb 22.
5
Association of circulating cardiac biomarkers with electrocardiographic abnormalities in chronic kidney disease.循环心脏生物标志物与慢性肾脏病心电图异常的关联。
Nephrol Dial Transplant. 2021 Dec 2;36(12):2282-2289. doi: 10.1093/ndt/gfaa296.
6
Coronary artery disease in dialysis patients: evidence synthesis, controversies and proposed management strategies.透析患者的冠状动脉疾病：证据综合、争议及建议的管理策略
J Nephrol. 2021 Feb;34(1):39-51. doi: 10.1007/s40620-020-00758-5. Epub 2020 May 29.
7
Optimal cut-off value of high-sensitivity troponin I in diagnosing myocardial infarction in patients with end-stage renal disease.高敏肌钙蛋白I在终末期肾病患者心肌梗死诊断中的最佳截断值
Medicine (Baltimore). 2020 Jan;99(5):e18580. doi: 10.1097/MD.0000000000018580.
8
Utility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKD.传统循环及基于成像的心脏生物标志物在透析前慢性肾脏病患者中的应用价值。
Clin J Am Soc Nephrol. 2015 Mar 6;10(3):515-29. doi: 10.2215/CJN.03600414. Epub 2014 Nov 17.
本文引用的文献
1
Elevated cardiac troponin T predicts cardiovascular events in asymptomatic continuous ambulatory peritoneal dialysis patients without a history of cardiovascular disease.心肌肌钙蛋白T升高可预测无心血管疾病病史的无症状持续性非卧床腹膜透析患者发生心血管事件。
Am J Nephrol. 2009;29(2):129-35. doi: 10.1159/000151634. Epub 2008 Aug 22.
2
Universal definition of myocardial infarction.心肌梗死的通用定义。
Eur Heart J. 2007 Oct;28(20):2525-38. doi: 10.1093/eurheartj/ehm355.
3
Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis.肌钙蛋白T和I在终末期肾病无症状患者中的预后价值：一项荟萃分析。
Circulation. 2005 Nov 15;112(20):3088-96. doi: 10.1161/CIRCULATIONAHA.105.560128.
4
Cardiac troponins and renal failure: the evolution of a clinical test.心肌肌钙蛋白与肾衰竭：一项临床检测的演变
Circulation. 2005 Nov 15;112(20):3036-7. doi: 10.1161/CIRCULATIONAHA.105.579888.
5
6
7
Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients.肾脏清除功能受损解释了血液透析患者肌钙蛋白T片段升高的原因。
Circulation. 2004 Jan 6;109(1):23-5. doi: 10.1161/01.CIR.0000109483.45211.8F. Epub 2003 Dec 22.
8
Prognostic value of cardiac markers in ESRD: Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) study.心脏标志物在终末期肾病中的预后价值：慢性血液透析与新型心脏标志物评估（CHANCE）研究
Am J Kidney Dis. 2003 Sep;42(3):513-23. doi: 10.1016/s0272-6386(03)00746-7.
9
Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis.心肌肌钙蛋白T和C反应蛋白在预测长期血液透析患者预后、冠状动脉粥样硬化及心肌病中的作用
JAMA. 2003 Jul 16;290(3):353-9. doi: 10.1001/jama.290.3.353.
10
Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease.心脏肌钙蛋白I和T对终末期肾病患者后续死亡的预测价值。
Circulation. 2002 Dec 3;106(23):2941-5. doi: 10.1161/01.cir.0000041254.30637.34.
Zotero 插件